1. Home
  2. SSKN vs GOVX Comparison

SSKN vs GOVX Comparison

Compare SSKN & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • GOVX
  • Stock Information
  • Founded
  • SSKN 1989
  • GOVX 2001
  • Country
  • SSKN United States
  • GOVX United States
  • Employees
  • SSKN N/A
  • GOVX N/A
  • Industry
  • SSKN Medical/Dental Instruments
  • GOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSKN Health Care
  • GOVX Health Care
  • Exchange
  • SSKN Nasdaq
  • GOVX Nasdaq
  • Market Cap
  • SSKN 8.9M
  • GOVX 7.6M
  • IPO Year
  • SSKN 2005
  • GOVX N/A
  • Fundamental
  • Price
  • SSKN $1.81
  • GOVX $0.70
  • Analyst Decision
  • SSKN Strong Buy
  • GOVX Strong Buy
  • Analyst Count
  • SSKN 1
  • GOVX 4
  • Target Price
  • SSKN $6.00
  • GOVX $10.50
  • AVG Volume (30 Days)
  • SSKN 43.9K
  • GOVX 1.3M
  • Earning Date
  • SSKN 08-13-2025
  • GOVX 07-28-2025
  • Dividend Yield
  • SSKN N/A
  • GOVX N/A
  • EPS Growth
  • SSKN N/A
  • GOVX N/A
  • EPS
  • SSKN N/A
  • GOVX N/A
  • Revenue
  • SSKN $33,620,000.00
  • GOVX $6,143,044.00
  • Revenue This Year
  • SSKN $3.31
  • GOVX N/A
  • Revenue Next Year
  • SSKN $9.67
  • GOVX N/A
  • P/E Ratio
  • SSKN N/A
  • GOVX N/A
  • Revenue Growth
  • SSKN 3.30
  • GOVX 1943.07
  • 52 Week Low
  • SSKN $1.78
  • GOVX $0.43
  • 52 Week High
  • SSKN $3.79
  • GOVX $11.18
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 33.32
  • GOVX 44.62
  • Support Level
  • SSKN $1.89
  • GOVX $0.66
  • Resistance Level
  • SSKN $1.97
  • GOVX $0.70
  • Average True Range (ATR)
  • SSKN 0.11
  • GOVX 0.06
  • MACD
  • SSKN -0.01
  • GOVX -0.00
  • Stochastic Oscillator
  • SSKN 9.09
  • GOVX 20.96

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: